Axogen, Inc. Impairment of Long-Lived Assets Held-for-use
Axogen, Inc. (AXGN) reported Impairment of Long-Lived Assets Held-for-use of $64.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2026-02-24
- Axogen, Inc. impairment of long-lived assets held-for-use for fiscal 2025 was $64.00K.
- Axogen, Inc. impairment of long-lived assets held-for-use for fiscal 2024 was $0.00.
- Axogen, Inc. impairment of long-lived assets held-for-use for fiscal 2023 was $0.00.
- Axogen, Inc. impairment of long-lived assets held-for-use for fiscal 2017 was $0.00.
| Period end | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|
| 2025-12-31 | $64.00K 10-K · filed 2026-02-24 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-24 |
| 2023-12-31 | $0.00 10-K · filed 2026-02-24 |
| 2017-12-31 | $0.00 10-K · filed 2018-02-28 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-28 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-01 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-29 |
| 2013-12-31 | $9.42K 10-K · filed 2015-03-05 |
| 2012-12-31 | $129.67K 10-K · filed 2014-03-06 |
| 2011-12-31 | $0.00 10-K/A · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |